Significant Ownership of Carlyle Group Inc.
- Notable people
- David Rubenstein
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Carlyle Group Inc. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Signature and title
- /s/ Anne K. Frederick - Anne K. Frederick, Corporate Secretary
- Location
- Washington, DC
Large-stake snapshot
1 signal
Manager identity
2 identity fields
Follow Filing Activity
Follow Carlyle Group Inc. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Carlyle Group Inc.
Significant Ownership of Carlyle Group Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SARO | StandardAero, Inc. | Common Stock, par value $0.01 per share | 25% | $2,230,560,113 | -$1,795,450,393 | 84,587,035 | -45% | Carlyle Group Inc. | 31 Mar 2026 |
| MDLN | Medline Inc. | Class A Common Stock, par value $0.0001 per share | 21% | $8,834,092,928 | -$1,332,516,432 | 187,083,713 | -13% | Carlyle Group Inc. | 31 Mar 2026 |
| COMM | CommScope Holding Company, Inc. | Common Stock, par value $0.01 per share | 18% | $363,715,540 | +$4,933,031 | 45,865,768 | +1.4% | The Carlyle Group Inc. | 03 Aug 2025 |
| SPWR | SunPower Inc. | Common Stock, par value $0.0001 per share | 5.4% | $10,025,296 | -$1,296,525 | 6,385,539 | -11% | Carlyle Group Inc. | 31 Dec 2025 |
| PHAT | Phathom Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 4.9% | $30,142,485 | 3,496,808 | Carlyle Group Inc. | 28 Aug 2025 | ||
| SPRB | Spruce Biosciences, Inc. | Common Stock, par value $0.0001 per share | 4.7% | $4,208,342 | 50,893 | The Carlyle Group Inc. | 18 Feb 2026 | ||
| JSPR | Jasper Therapeutics, Inc. | Voting Common Stock, par value $0.0001 per share | 3.8% | $1,665,114 | 1,088,310 | The Carlyle Group Inc. | 18 Feb 2026 | ||
| NCNA | NuCana plc | Ordinary Shares, nominal value (pound)0.04 per share | 2.4% | $1,920,835 | 3,430,062 | The Carlyle Group Inc. | 18 Apr 2025 | ||
| BSM | Black Stone Minerals, L.P. | Common Units | 0% | $0 | 0 | The Carlyle Group Inc. | 31 Mar 2025 |
Schedules 13D/G Reported by Carlyle Group Inc.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.